Cadila Healthcare informs about press release

14 Jun 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated June 14, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets’. Bring this news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

913.90 -7.35 (-0.80%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×